World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
40259
World Ranking
5613
National Ranking
3019

Overview

Glenn Heller is affiliated with Memorial Sloan Kettering Cancer Center in the United States and has contributed extensively to medical research, primarily within the field of Medicine. Their research focuses mainly on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, and Statistics and Probability.

Their work addresses a range of clinical topics, with a significant emphasis on cancer treatment and diagnosis. Major themes include:

  • Prostate Cancer Treatment and Research
  • Lung Cancer Treatments and Mutations
  • Prostate Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Lung Cancer Research Studies
  • PARP inhibition in cancer therapy
  • Colorectal Cancer Treatments and Studies

Heller frequently publishes in prominent oncology and clinical journals. The principal venues for their research include:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • JCO Precision Oncology
  • Annals of Oncology
  • Journal of Thoracic Oncology

Recent key publications by Heller span topics in lung and prostate cancer, reflecting clinical and molecular oncology insights. Selected papers include:

  • The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer, 2020, Clinical Cancer Research
  • Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations, 2020, JCO Precision Oncology
  • Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers, 2020, JAMA Oncology
  • Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer, 2021, Clinical Cancer Research
  • The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer, 2022, Immunity

Collaboration is an important aspect of Heller's research ecosystem, with frequent co-authors including:

  • Michael J. Morris
  • Gregory J. Riely
  • Charles M. Rudin
  • Helena A. Yu
  • Mark G. Kris

These partnerships support work across various aspects of oncology, from molecular cancer characterization to therapeutic outcomes. Heller's publications and collaboration patterns highlight a commitment to advancing understanding of cancer biology and treatment modalities through multidisciplinary approaches.

Best Publications

  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

    Renier J. Brentjens;Isabelle Rivière;Jae H. Park;Marco L. Davila

  • Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

    L. J. Steinherz;P. G. Steinherz;C. T C. Tan;G. Heller

  • Genomic correlates of clinical outcome in advanced prostate cancer.

    Wassim Abida;Joanna Cyrta;Joanna Cyrta;Glenn Heller;Davide Prandi

  • Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

    P A Meyers;G Heller;J Healey;A Huvos

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza

  • Concordance probability and discriminatory power in proportional hazards regression

    Mithat Gönen;Glenn Heller

  • Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

    Howard I Scher;Howard I Scher;Xiaoyu Jia;Johann S de Bono;Martin Fleisher

  • Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin

    Chad May;Stefano Rivella;John Callegari;Glenn Heller

  • Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

    Ethan Basch;Xiaoyu Jia;Glenn Heller;Allison Barz

  • Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.

    Howard I. Scher;David Lu;Nicole A. Schreiber;Jessica Louw

  • Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes

    Katharine C. Hsu;Carolyn A. Keever-Taylor;Carolyn A. Keever-Taylor;Carolyn A. Keever-Taylor;Andrew Wilton;Andrew Wilton;Andrew Wilton;Clara Pinto;Clara Pinto;Clara Pinto

  • Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation : Effect of patient age and donor leukocyte infusions

    T.N. Small;E.B. Papadopoulos;F. Boulad;P. Black

  • Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

    E Berman;G Heller;J Santorsa;S McKenzie

  • 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/neu and Inhibits the Growth of Prostate Cancer Xenografts

    David B. Solit;Fuzhong F. Zheng;Maria Drobnjak;Pamela N. Münster

  • Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions

    Adam M. Boruchov;Glenn Heller;Maria-Concetta Veri;Ezio Bonvini

  • Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.

    C Balmaceda;G Heller;M Rosenblum;B Diez

  • Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

    Ekaterina Doubrovina;Banu Oflaz-Sozmen;Susan E. Prockop;Nancy A. Kernan

  • Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

    P. A. Meyers;G. Heller;J. H. Healey;A. Huvos

  • Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid

    Linda Vahdat;Peter Maslak;Wilson H. Miller;Anna Eardley

  • Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer

    David R Shaffer;Margaret A Leversha;Daniel C Danila;Oscar Lin

Frequent Co-Authors

Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Richard J. O'Reilly
Richard J. O'Reilly Memorial Sloan Kettering Cancer Center
Marcel R.M. van den Brink
Marcel R.M. van den Brink Memorial Sloan Kettering Cancer Center
Nancy A. Kernan
Nancy A. Kernan Memorial Sloan Kettering Cancer Center
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Nai-Kong V. Cheung
Nai-Kong V. Cheung Memorial Sloan Kettering Cancer Center
Katharine C. Hsu
Katharine C. Hsu Memorial Sloan Kettering Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Michel Sadelain
Michel Sadelain Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re enthusiastic about a career in healthcare but not certain medical school is the only path, there are a variety of related online degrees and certifications that can prepare you for in-demand roles. For those who want to advance their nursing careers, enrolling in a 1 year dnp program online offers a fast track to becoming a Doctor of Nursing Practice, often required for leadership positions.

Interested in pharmaceuticals? You can obtain your doctoral credentials and minimize student debt by searching for the cheapest online pharmacy school. This pathway can lead to a dynamic career as a licensed pharmacist.

The technological backbone of healthcare is rapidly growing. Earning a degree in health informatics will position you at the intersection of data, technology, and patient care, opening doors to roles in health data analysis and information systems management.

If you prefer a specialized skill set with flexible job options, consider pursuing a medical coding certification. This qualification can be attained quickly online and is highly valued in hospitals, clinics, and private practices. Each of these online options offers a viable alternative to traditional medical studies and helps you build a rewarding healthcare career.

Best Scientists Citing Glenn Heller

Trending Scientists